Discipline | Cardiology |
---|---|
Language | English |
Edited by | Catherine Otto |
Publication details | |
Former name(s) | British Heart Journal |
History | 1939-present |
Publisher | |
Frequency | Biweekly |
Hybrid | |
5.1 (2023) | |
Standard abbreviations | |
ISO 4 | Heart |
Indexing | |
CODEN | HEARFR |
ISSN | 1355-6037 (print) 1468-201X (web) |
OCLC no. | 34055332 |
Links | |
Heart is a biweekly peer-reviewed medical journal covering all areas of cardiovascular medicine and surgery. It is the official journal of the British Cardiovascular Society. It was established in 1939 as the British Heart Journal and is published by the BMJ Group. [1] The name was changed from British Heart Journal to Heart in 1996 with the start of volume 75. The editor-in-chief is Catherine Otto (University of Washington). [1]
A sister journal, Open Heart , was established in 2010 with the aim of covering cardiovascular research with less emphasis on novelty or priority. [2]
In 2010, Heart established a sister journal, Heart Asia. It was the official journal of the Asia Pacific Heart Association and aimed to focus on cardiovascular research in the Asia Pacific region. [3] In 2019, the journal ceased publication.
The journal is abstracted and indexed by Index Medicus, Science Citation Index Expanded, EMBASE, and Scopus. According to the Journal Citation Reports , its 2023 impact factor is 5.1, ranking it 38th out of 222 journals in the category "Cardiac and Cardiovascular Systems". [4]
The following persons have been editor-in-chief of the journal:
According to Scopus, the following three articles from Heart have been cited most often (>700 times): [5]
Cardiovascular disease (CVD) is any disease involving the heart or blood vessels. CVDs constitute a class of diseases that includes: coronary artery diseases, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, thromboembolic disease, and venous thrombosis.
Quinidine is a class IA antiarrhythmic agent used to treat heart rhythm disturbances. It is a diastereomer of antimalarial agent quinine, originally derived from the bark of the cinchona tree. The drug causes increased action potential duration, as well as a prolonged QT interval. As of 2019, its IV formulation is no longer being manufactured for use in the United States.
Mitral stenosis is a valvular heart disease characterized by the narrowing of the opening of the mitral valve of the heart. It is almost always caused by rheumatic valvular heart disease. Normally, the mitral valve is about 5 cm2 during diastole. Any decrease in area below 2 cm2 causes mitral stenosis. Early diagnosis of mitral stenosis in pregnancy is very important as the heart cannot tolerate increased cardiac output demand as in the case of exercise and pregnancy. Atrial fibrillation is a common complication of resulting left atrial enlargement, which can lead to systemic thromboembolic complications such as stroke.
The QT interval is a measurement made on an electrocardiogram used to assess some of the electrical properties of the heart. It is calculated as the time from the start of the Q wave to the end of the T wave, and approximates to the time taken from when the cardiac ventricles start to contract to when they finish relaxing. An abnormally long or abnormally short QT interval is associated with an increased risk of developing abnormal heart rhythms and sudden cardiac death. Abnormalities in the QT interval can be caused by genetic conditions such as long QT syndrome, by certain medications such as sotalol or pitolisant, by disturbances in the concentrations of certain salts within the blood such as hypokalaemia, or by hormonal imbalances such as hypothyroidism.
Cardiomegaly is a medical condition in which the heart becomes enlarged. It is more commonly referred to simply as "having an enlarged heart". It is usually the result of underlying conditions that make the heart work harder, such as obesity, heart valve disease, high blood pressure (hypertension), and coronary artery disease. Cardiomyopathy is also associated with cardiomegaly.
Unstable angina is a type of angina pectoris that is irregular or more easily provoked. It is classified as a type of acute coronary syndrome.
Da Costa's syndrome, also known as soldier's heart among other names, was a syndrome or a set of symptoms similar to those of heart disease. These include fatigue upon exertion, shortness of breath, palpitations, sweating, chest pain, and sometimes orthostatic intolerance. It was originally thought to be a cardiac condition, and treated with a predecessor to modern cardiac drugs. In modern times, it is believed to represent several unrelated disorders, some of which have a known medical basis.
Uhl anomaly is a rare cardiac malformation that was first identified by Dr. Henry Uhl in 1952. It is characterized by the absence of the right ventricle (RV) myocardium, either entirely or partially, and the replacement of the RV myocardium by nonfunctional fibroelastic tissue that resembles parchment. As of 2010 less than 100 cases have been reported in literature.
Sodium channel protein type 5 subunit alpha, also known as NaV1.5 is an integral membrane protein and tetrodotoxin-resistant voltage-gated sodium channel subunit. NaV1.5 is found primarily in cardiac muscle, where it mediates the fast influx of Na+-ions (INa) across the cell membrane, resulting in the fast depolarization phase of the cardiac action potential. As such, it plays a major role in impulse propagation through the heart. A vast number of cardiac diseases is associated with mutations in NaV1.5 (see paragraph genetics). SCN5A is the gene that encodes the cardiac sodium channel NaV1.5.
Left atrial enlargement (LAE) or left atrial dilation refers to enlargement of the left atrium (LA) of the heart, and is a form of cardiomegaly.
Himmatrao Saluba Bawaskar is an Indian physician from Mahad, Maharashtra. He is known for his research on treatment for scorpion stings. Much of his work has been published in the British medical journal The Lancet. He has also conducted research in the fields of snake bites, cardiovascular diseases, and hypothyroidism.
QRISK3 is a prediction algorithm for cardiovascular disease (CVD) that uses traditional risk factors together with body mass index, ethnicity, measures of deprivation, family history, chronic kidney disease, rheumatoid arthritis, atrial fibrillation, diabetes mellitus, and antihypertensive treatment.
Heart rhythm disturbances have been seen among astronauts. Most of these have been related to cardiovascular disease, but it is not clear whether this was due to pre-existing conditions or effects of space flight. It is hoped that advanced screening for coronary disease has greatly mitigated this risk. Other heart rhythm problems, such as atrial fibrillation, can develop over time, necessitating periodic screening of crewmembers’ heart rhythms. Beyond these terrestrial heart risks, some concern exists that prolonged exposure to microgravity may lead to heart rhythm disturbances. Although this has not been observed to date, further surveillance is warranted.
Walter Somerville CBE (1913–2005) was an Irish cardiologist who played a leading role in heart surgery at London's Middlesex and Harefield hospitals.
The British Cardiovascular Society (BCS) is a United Kingdom-wide health organisation based in London. It aims to represent all healthcare professionals working in the field of cardiology, set standards for prevention, diagnosis, and clinical care, and communicate those standards to the community and the patients through training, education and public outreach.
Sir William Errington Hume was a British physician and cardiologist.
John Crighton Bramwell (1889–1976) was a British cardiologist, professor of medicine, and one of the founders of cardiology as a specialist subject in the UK.
Brigadier Davis Evan Bedford (1898–1978) was a British physician and cardiologist.
John Maurice Hardman Campbell (1891–1973) was a British physician, cardiologist, and medical journal editor.
John Parsons Shillingford was a British physician and cardiologist, known as a pioneer of the introduction of coronary care units in the United Kingdom in the 1960s.
{{cite journal}}
: CS1 maint: DOI inactive as of November 2024 (link)